Medibank is advocating for a significant expansion of hospital care in the home to ease pressure on the traditional hospital system. A new KPMG report commissioned by Medibank outlines potential economic benefits of this approach, estimating that by 2030, up…
Henry Schein Medical, part of Henry Schein, Inc. (Nasdaq: HSIC), is exhibiting at the EMS & FIRE PRO Expo from October 24-26, 2024. Located at booth #718, the exhibit features a range of products and technologies aimed at advancing the…
Elucid has announced that Noridian will begin covering AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, starting December 8, 2024. With this decision, five out of seven Medicare Administrative Contractors (MACs) will offer coverage for this…
Jupiter Endovascular, Inc., a medical technology startup focused on pioneering endovascular procedures with its Endoportal Control™ platform, has announced the successful treatment of the first U.S. patient in the SPIRARE II pivotal study. This study evaluates the Vertex Pulmonary Embolectomy…
Vertex Pharmaceuticals (Nasdaq: VRTX) has shared updates on its pipeline for kidney diseases, including IgA nephropathy (IgAN), primary membranous nephropathy (pMN), and APOL1-mediated kidney disease (AMKD). The updates highlight the potential of Vertex’s investigational therapies, showcasing positive new data on…
Centene Corporation (NYSE: CNC) has announced its financial results for the third quarter ending September 30, 2024. Key highlights include: CEO Sarah M. London noted, “Our diversified portfolio has allowed us to successfully navigate a dynamic landscape this quarter. We…
Siemens Healthineers is revolutionizing clinical lab automation by consolidating 25 tasks typically performed manually by staff, significantly reducing manual workflow steps by 75%. Traditional lab automation relies on a track system to transport samples, but the Atellica Integrated Automation system…
HCA Healthcare, Inc. (NYSE: HCA) has released its financial results for the third quarter ending September 30, 2024. Key Metrics: CEO Sam Hazen praised the team for their response to recent hurricanes, emphasizing their commitment to patient care. Q3 Performance…
The CVS Health® Foundation has announced a $1.5 million funding initiative to enhance access to healthcare services, medically tailored meals, and transportation for chronic disease patients in Atlanta. This funding will support partnerships with Good Samaritan Health Center, Open Hand…
WellSky, a prominent technology company in health and community care, has announced its acquisition of Bonafide, a software solution designed for durable medical equipment (DME) and home medical equipment (HME) providers. This acquisition enhances WellSky’s presence in the DME/HME sector,…
Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883, CEO: Haru Morita) has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to MDL-101, a novel precision medicine for congenital muscular dystrophy type 1A (LAMA2-CMD). Modalis…
Maze Therapeutics, a biopharmaceutical company focused on developing precision medicines using human genetics, has announced positive results from the Phase 1 clinical trial of MZE829 in healthy volunteers. MZE829 is an oral small molecule that inhibits APOL1, which Maze is…